To help guide meat industry stakeholders through the new labeling process, USDA’s Food Safety Inspection Service (FSIS) will ...

The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that's likely to ...

A new “Non-UPF” certification label will soon help Americans easily identify foods that are not ultra-processed, providing clearer guidance in grocery aisles. The certification, created by the Non-UPF ...

Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...

Studies in the early 2000s claimed there were major risks associated with HRT. The Food and Drug Administration said Monday it will remove the "black box" warning from hormone replacement therapy (HRT ...

What leads people to make better food choices? Is it price, availability, health attributes of the food or something else? This is the million-dollar question. The most common statement I hear from my ...

Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to acetaminophen after the Trump administration linked its use during pregnancy to ...

Kenvue, the owners of Tylenol, are pushing back on claims that acetaminophen—the chemical compound in their popular over-the-counter painkiller—may cause autism in children when used by pregnant ...

The FDA last overhauled its Nutrition Facts label in 2016. Now, a decade later, new food and beverage label changes are expected to roll out. What’s on your label? It may be changing soon. The Food ...

The FDA has adjusted the label of Johnson & Johnson and Legend Biotech’s Carvykti, warning patients and doctors that use of the multiple myeloma treatment could increase the risk of an intestinal ...

U.S. health officials are quickly taking regulatory action to build on findings from the administration’s research push into the “autism epidemic,” including a label update for a decades-old GSK drug ...